Cargando…
Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants
Inflammatory breast cancer (IBC) is an aggressive form of locally advanced breast cancer (LABC) that effects approximately 5% of women with breast cancer annually in the USA. It is a clinically and pathologically distinct form of LABC that is particularly fast growing, invasive, and angiogenic. Near...
Autores principales: | Kleer, Celina G, van Golen, Kenneth L, Merajver, Sofia D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138665/ https://www.ncbi.nlm.nih.gov/pubmed/11250736 http://dx.doi.org/10.1186/bcr89 |
Ejemplares similares
-
WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer
por: Kleer, Celina G, et al.
Publicado: (2004) -
RhoC Impacts the Metastatic Potential and Abundance of Breast Cancer Stem Cells
por: Rosenthal, Devin T., et al.
Publicado: (2012) -
Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells
por: Zhang, Yanhong, et al.
Publicado: (2005) -
The Third International Inflammatory Breast Cancer Conference
por: van Golen, Kenneth L, et al.
Publicado: (2013) -
Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells
por: Hendrix, Mary JC, et al.
Publicado: (2000)